We previously demonstrated [17] that the ability of Xen to amplify the effects of GIP on insulin and glucagon release is greatest in humans with impaired glucose tolerance and therefore, only subjects with impaired glucose tolerance were studied. Here, INS is linked to Impaired glucose tolerance.